Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Maximus Berger"'
Autor:
Subash Raj Susai, Colm Healy, David Mongan, Meike Heurich, Jonah F. Byrne, Mary Cannon, Gerard Cagney, Kieran Wynne, Connie Markulev, Miriam R. Schäfer, Maximus Berger, Nilufar Mossaheb, Monika Schlögelhofer, Stefan Smesny, Ian B. Hickie, Gregor E. Berger, Eric Y. H. Chen, Lieuwe de Haan, Dorien H. Nieman, Merete Nordentoft, Anita Riecher-Rössler, Swapna Verma, Rebekah Street, Andrew Thompson, Alison Ruth Yung, Barnaby Nelson, Patrick D. McGorry, Melanie Föcking, G. Paul Amminger, David Cotter
Publikováno v:
Translational Psychiatry, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Preliminary evidence indicates beneficial effects of omega-3 polyunsaturated fatty acids (PUFAs) in early psychosis. The present study investigates the molecular mechanism of omega-3 PUFA-associated therapeutic effects in clinical high-risk
Externí odkaz:
https://doaj.org/article/ef015f3560c34a10bba31b92235544a1
Autor:
Nicholas Cheng, Alison McLaverty, Barnaby Nelson, Connie Markulev, Miriam R. Schäfer, Maximus Berger, Nilufar Mossaheb, Monika Schlögelhofer, Stefan Smesny, Ian B. Hickie, Gregor E. Berger, Eric Y. H. Chen, Lieuwe de Haan, Dorien H. Nieman, Merete Nordentoft, Anita Riecher-Rössler, Swapna Verma, Rebekah Street, Andrew Thompson, Hok Pan Yuen, Robert Hester, Alison Ruth Yung, Patrick D. McGorry, Kelly Allott, G. Paul Amminger
Publikováno v:
BJPsych Open, Vol 8 (2022)
Background Cognitive impairments are well-established features of psychotic disorders and are present when individuals are at ultra-high risk for psychosis. However, few interventions target cognitive functioning in this population. Aims To investig
Externí odkaz:
https://doaj.org/article/1c197a196a8743dab31ab6e7f51f47da
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/bd357e8edc1a4a129b5991880e66c965
Autor:
Maximus Berger, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam R. Schäfer, Nilufar Mossaheb, Monika Schlögelhofer, Stefan Smesny, Ian B. Hickie, Gregor E. Berger, Eric Y. H. Chen, Lieuwe de Haan, Dorien H. Nieman, Merete Nordentoft, Anita Riecher-Rössler, Swapna Verma, Todd W. Mitchell, Barbara J. Meyer, Andrew Thompson, Alison Ruth Yung, Patrick D. McGorry, G. Paul Amminger
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/40f78615095149b8b106023c773e4673
Autor:
Maximus Berger, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam R. Schäfer, Nilufar Mossaheb, Monika Schlögelhofer, Stefan Smesny, Ian B. Hickie, Gregor E. Berger, Eric Y. H. Chen, Lieuwe de Haan, Dorien H. Nieman, Merete Nordentoft, Anita Riecher-Rössler, Swapna Verma, Todd W. Mitchell, Barbara J. Meyer, Andrew Thompson, Alison Ruth Yung, Patrick D. McGorry, G. Paul Amminger
Publikováno v:
Frontiers in Psychiatry, Vol 10 (2019)
BackgroundDeficiencies in membrane polyunsaturated fatty acids (PUFA) such as omega-3 (n-3) fatty acids are thought to contribute to the pathophysiological processes underlying psychotic disorders. Emerging evidence suggests that the levels of PUFA a
Externí odkaz:
https://doaj.org/article/df0c2ce4a5e24a5aa8a784f6408c8c23
Autor:
David Cotter, Miriam R. Schäfer, G. Paul Amminger, Maximus Berger, Monika Schlögelhofer, Nilufar Mossaheb, Subash Raj Susai, Stefan Smesny, Colm Healy, Connie Markulev, Andrew Thompson, Ian B. Hickie, Anita Riecher-Rössler, Swapna Verma, Mary Cannon, Dorien H. Nieman, David Mongan, Alison R. Yung, Patrick D. McGorry, Eric Y.H. Chen, Merete Nordentoft, Lieuwe de Haan, Melanie Föcking, Gregor Berger, Barnaby Nelson
Publikováno v:
Brain, behavior, and immunity, 99, 147-156. Academic Press Inc.
Background There is increasing evidence that dysregulation of polyunsaturated fatty acids (FAs) mediated membrane function plays a role in the pathophysiology of schizophrenia. Even though preclinical findings have supported the anti-inflammatory pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ff5bd7aa91246f376843becaa0e1f6f
https://doi.org/10.1016/j.bbi.2021.09.018
https://doi.org/10.1016/j.bbi.2021.09.018
Autor:
Richard C. Kevin, Jonathon C. Arnold, Iain S. McGregor, Peter T. Doohan, Lyndsey L. Anderson, Maximus Berger, G. Paul Amminger, Lachlan D. Oldfield
Publikováno v:
Journal of Clinical Psychopharmacology. 41:525-533
Background Cannabidiol (CBD), a major nonintoxicating constituent of cannabis, exhibits anxiolytic properties in preclinical and human studies and is of interest as a novel intervention for treating anxiety disorders. Existing first-line pharmacother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c94e1ff6c1432a225987a40b98613aa
https://doi.org/10.1097/jcp.0000000000001427
https://doi.org/10.1097/jcp.0000000000001427
Autor:
Patrick D. McGorry, G.P. Amminger, E Burkhardt, HP Yuen, Shona M. Francey, Alison R. Yung, Andrew Thompson, Stephen J. Wood, Ashleigh Lin, Maximus Berger, Barnaby Nelson, Robert H. Yolken
Publikováno v:
Schizophrenia Research. 233:24-30
Background Ultra high-risk (UHR) criteria were introduced to identify people at imminent risk of developing psychosis. To improve prognostic accuracy, additional clinical and biological risk factors have been researched. Associations between psychoti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7eb07989e30250935ae5aa81258fd3d
https://doi.org/10.1016/j.schres.2021.06.012
https://doi.org/10.1016/j.schres.2021.06.012
Autor:
Eoin Killackey, Cathy Mihalopoulos, Maximus Berger, Andrea Baker, James Scott, Jessica Spark, Iain S. McGregor, Hok Pan Yuen, David Cotter, Melissa Kerr, Alison R. Yung, Andrew Thompson, Sally O'Callaghan, Scott R. Clark, Patrick D. McGorry, Amber Weller, Brian O'Donoghue, G. Paul Amminger, Barnaby Nelson, Charlotte Pugh, Ashleigh Lin, Zoltán Sarnyai
Publikováno v:
Early Intervention in Psychiatry. 16:419-432
Background No biological treatment has been firmly established for the at-risk stage of psychotic disorder. In this study we aim to test if subthreshold psychotic symptoms can be effectively treated with cannabidiol (CBD), a non-psychoactive compound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a03712421c8d41c8e97ca6b28ac897fd
https://doi.org/10.1111/eip.13182
https://doi.org/10.1111/eip.13182
Autor:
Maximus, Berger, Emily, Li, Simon, Rice, Christopher G, Davey, Aswin, Ratheesh, Sophie, Adams, Henry, Jackson, Sarah, Hetrick, Alexandra, Parker, Tim, Spelman, Richard, Kevin, Iain S, McGregor, Patrick, McGorry, G Paul, Amminger
Publikováno v:
The Journal of Clinical Psychiatry. 83
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3ead8f31691385e67caca2039fe17cc
https://doi.org/10.4088/jcp.21m14130
https://doi.org/10.4088/jcp.21m14130